As of May 2024 CRISPR Therapeutics has a market cap of $4.77 Billion. This makes CRISPR Therapeutics the world's 2755th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $4.77 B | -3.99% |
2023 | $4.97 B | 56.24% |
2022 | $3.18 B | -45.12% |
2021 | $5.79 B | -46.81% |
2020 | $10.90 B | 194.5% |
2019 | $3.70 B | 149.9% |
2018 | $1.48 B | 56.74% |
2017 | $0.94 B | 17.19% |
2016 | $0.80 B |
On May 18th, 2024 the market cap of CRISPR Therapeutics was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | $0.61 B | -87.06% | ๐บ๐ธ USA |